58-17-102. Exceptions.
No coverage is required under §§58-17-100 to 58-17-106, inclusive, for the following:
(1)Any drug that has not been fully licensed or approved by the FDA;
(2)The use of any drug if the FDA has determined that use to be contraindicated; or
(3)Any experimental drug not otherwise approved for any indication by the FDA.
Source: SL 2000, ch 242, §3.